The Trump administration’s restored federal research funding to Columbia University's landmark diabetes study. But the impact of the cuts are lasting.

An investigational therapy from Alnylam did not significantly lower blood pressure in a key Phase 2 trial, new data show, but the drug is being advanced to a late-stage study.

The results suggest that lung xenotransplantation could one day become an option, but they also point to how much more work ...

The end of Covid vaccine emergency authorizations may limit the availability of shots for young, healthy kids.

Medical research is becoming more aligned with global disease burden as a side effect of chronic diseases becoming more ...

The comments related to financial challenges included references to their own or others’ grants being terminated, delays in ...

Susan Monarez, the first Senate-confirmed director of the Centers for Disease Control and Prevention, has been ousted after ...

A new heart risk model had raised questions about who should take statins. A new study to "right-size" yields a similar ...

Vaccines must be easy to get, free at the point of care, and clearly recommended, writes former NYC Health Commissioner Dave A. Chokshi.

A person who traveled to El Salvador has been diagnosed with New World screwworm — the first reported U.S. case tied to ...

Images of President Trump’s bruised hand have renewed attention to his health in general and his cardiovascular health in ...

The industry group MassBio has released its annual temperature check on the biotech industry in Massachusetts, and the ...